- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/165 - Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
Patent holdings for IPC class A61K 31/165
Total number of patents in this class: 3580
10-year publication summary
|
288
|
239
|
277
|
273
|
287
|
317
|
303
|
278
|
212
|
57
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Novartis AG | 11238 |
48 |
| The Regents of the University of California | 18943 |
47 |
| Newron Pharmaceuticals S.p.A. | 72 |
43 |
| Les Laboratoires Servier | 599 |
41 |
| Allergan, Inc. | 2600 |
29 |
| GW Research Limited | 402 |
23 |
| The General Hospital Corporation | 4517 |
19 |
| Murray and Poole Enterprises Limited | 23 |
19 |
| President and Fellows of Harvard College | 5792 |
18 |
| LTS Lohmann Therapie-Systeme AG | 691 |
18 |
| Indiana University Research and Technology Corporation | 808 |
17 |
| Novartis Pharma GmbH | 350 |
17 |
| Bristol-myers Squibb Company | 5080 |
16 |
| Board of Regents, The University of Texas System | 5370 |
16 |
| Dana-Farber Cancer Institute, Inc. | 2455 |
16 |
| Children's Medical Center Corporation | 1780 |
14 |
| Synta Pharmaceuticals Corp. | 204 |
14 |
| Vanda Pharmaceuticals, Inc. | 336 |
14 |
| The Trustees of the University of Pennsylvania | 4122 |
13 |
| BIAL - Portela & CA, S.A. | 243 |
13 |
| Other owners | 3125 |